MelissaFBairdMD

Assistant Professor of Medicine, University Alabama

Are you Dr. Baird?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. Melissa Baird, MD is an oncologist in Anniston, Alabama. She is currently licensed to practice medicine in Alabama and Texas. She is affiliated with RMC-Stringfellow Memorial Hospital and is an Assistant Professor of Medicine at University Alabama.

University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1992 - 1995
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1992
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 1986 - 1989
University of Texas Southwestern Medical SchoolClass of 1986

PubMed

A case of acute promyelocytic leukemia without RARα rearrangement and apparently normal cytogenetics.
Christos Vaklavas, Mark R. Steciuk, Yongsheng Ren, Melissa F. Baird, Fady M. Mikhail, James M. Foran> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Dec 1
120 citations
Warfarin dosing in patients with impaired kidney function.
Nita A. Limdi, Mohit A. Limdi, Larisa H. Cavallari, Aaron M. Anderson, Michael R. Crowley, Melissa F. Baird, Michael Allon, T. Mark Beasley> ;American Journal of Kidney Diseases. 2010 Nov 1
217 citations
Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
Nita A. Limdi, T. Mark Beasley, Melissa F. Baird, Joyce A. Goldstein, Gerald McGwin, Donna K. Arnett, Ronald T. Acton, Michael Allon> ;Journal of the American Society of Nephrology. 2009 Apr 1
172 citations
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
, , , , , , , , , , , , , , , , , , , > ;Journal of the National Comprehensive Cancer Network. 2008 Sep 1
188 citations
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.
Nita A. Limdi, Gerald McGwin, Joyce A. Goldstein, T. Beasley, Donna K. Arnett, Brian K. Adler, Melissa F. Baird, Ronald T. Acton> ;Clinical Pharmacology and Therapeutics. 2008 Feb 1
Join now to see all

Hims & Hers Completes Acquisition of ApostropheJuly 7th, 2021
Hims & Hers Deepens Dermatology Investment, Acquires ApostropheJune 24th, 2021
Hims & Hers Making Its Mark in Teledermatology with Apostrophe AcquisitionJune 24th, 2021
Join now to see all